Genome-wide association studies (GWAS) have associated polymorphisms in inflammasome-related genes—such as NLRP3, CARD9, and NOD2 [17,103]—with increased IBD risk, particularly in Crohn’s disease. This evidence concerns the gene NLRP3 and inflammatory bowel disease.